HistCite - The Kidney Transplant Papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
201	2281 Sakamoto T, Ye Q, Lu L, Demetris AJ, Starzl TE, et al. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts TRANSPLANTATION. 1999 MAR 27; 67 (6): 833-840	17	22	10	28
202	2322 Wekerle T, Sykes M Mixed chimerism as an approach for the induction of transplantation tolerance TRANSPLANTATION. 1999 AUG 27; 68 (4): 459-467	17	103	9	117
203	2430 VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, et al. Human allograft acceptance is associated with immune regulation JOURNAL OF CLINICAL INVESTIGATION. 2000 JUL; 106 (1): 145-155	17	171	8	60
204	2468 Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, et al. Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both TRANSPLANTATION. 2000 DEC 15; 70 (11): 1632-1641	17	34	17	48
205	3 STARZL TE, RIFKIND D, MOORE CA, WADDELL WR, PORTER KA, et al. RENAL HOMOTRANSPLANTATION - LATE FUNTION + COMPLICATIONS ANNALS OF INTERNAL MEDICINE. 1964; 61 (3): 470-&	16	104	2	50
206	10 DEMPSTER WJ, SHACKMAN R, HARRISON CV REJECTION PROCESSES IN HUMAN HOMOTRANSPLANTED KIDNEYS BRITISH MEDICAL JOURNAL. 1964; 2 (541): 969-&	16	72	1	27
207	17 PORTER KA, ZUKOSKI CF, CALNE RY VASCULAR + OTHER CHANGES IN 200 CANINE RENAL HOMOTRANSPLANTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS LABORATORY INVESTIGATION. 1964; 13 (7): 809-&	16	97	1	37
208	718 BEVERIDGE T, GRATWOHL A, MICHOT F, NIEDERBERGER W, NUESCH E, et al. CYCLOSPORIN-A - PHARMACOKINETICS AFTER A SINGLE DOSE IN MAN AND SERUM LEVELS AFTER MULTIPLE DOSING IN RECIPIENTS OF ALLOGENEIC BONE-MARROW GRAFTS CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. 1981; 30 (1): 5-18	16	161	1	27
209	741 IWATSUKI S, IWAKI Y, KANO T, KLINTMALM G, KOEP LJ, et al. SUCCESSFUL LIVER-TRANSPLANTATION FROM CROSSMATCH-POSITIVE DONORS TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 286-288	16	91	3	7
210	1227 Tzakis AG, REYES J, TODO S, GREEN M, OHYA T, et al. FK-506 VERSUS CYCLOSPORINE IN PEDIATRIC LIVER-TRANSPLANTATION TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3010-3015	16	39	7	15
#	Date / Author / Journal	LCS	GCS	LCR	CR
211	1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al. CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506 TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145	16	44	5	8
212	1470 REDING R, WALLEMACQ PE, LAMY ME, RAHIER J, SEMPOUX C, et al. CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS - EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN TRANSPLANTATION. 1994 JAN; 57 (1): 93-100	16	63	4	23
213	1482 BACKMAN L, NICAR M, LEVY M, DISTANT D, EISENSTEIN C, et al. FK506 TROUGH LEVELS IN WHOLE-BLOOD AND PLASMA IN LIVER-TRANSPLANT RECIPIENTS - CORRELATION WITH CLINICAL EVENTS AND SIDE-EFFECTS TRANSPLANTATION. 1994 FEB 27; 57 (4): 519-525	16	80	4	29
214	1519 PEARSON TC, ALEXANDER DZ, WINN KJ, LINSLEY PS, LOWRY RP, et al. TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-IG TRANSPLANTATION. 1994 JUN 27; 57 (12): 1701-1706	16	281	1	42
215	1618 NEUHAUS P, BLUMHARDT G, BECHSTEIN WO, PLATZ KP, JONAS S, et al. COMPARISON OF FK506-BASED AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER- TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE TRANSPLANTATION. 1995 JAN 15; 59 (1): 31-40	16	103	5	33
216	1757 Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, et al. Clinical pharmacokinetics of tacrolimus CLINICAL PHARMACOKINETICS. 1995 DEC; 29 (6): 404-430	16	291	36	147
217	2024 Ueda M, Hundrieser J, Hisanaga M, Tanaka K, Wonigeit K, et al. Development of microchimerism in pediatric patients after living-related liver transplantation CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 193-200	16	28	12	26
218	2334 Lu L, Li W, Zhong CP, Qian SG, Fung JJ, et al. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb TRANSPLANTATION. 1999 SEP 27; 68 (6): 747-757	16	47	23	58
219	2472 Wekerle T, Sykes M Mixed chimerism and transplantation tolerance ANNUAL REVIEW OF MEDICINE. 2001; 52: 353-+	16	106	10	106
220	2693 Pons JA, Yelamos J, Ramirez P, Oliver-Bonet M, Sanchez A, et al. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression TRANSPLANTATION. 2003 APR 15; 75 (7): 1045-1047	16	43	8	10
#	Date / Author / Journal	LCS	GCS	LCR	CR
221	2773 Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, et al. Lessons of organ-induced tolerance learned from historical clinical experience TRANSPLANTATION. 2004 MAR 27; 77 (6): 926-929	16	29	14	25
222	2917 Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence JOURNAL OF HEPATOLOGY. 2006 APR; 44 (4): 702-709	16	59	8	38
223	3029 Alexander SI, Smith N, Hu M, Verran D, Shun A, et al. Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 369-374	16	58	6	24
224	13 REEMTSMA K, SCHLEGEL JU, DEWITT CW, MCCRACKEN BH, PEARL MA, et al. REVERSAL OF EARLY GRAFT REJECTION AFTER RENAL HETEROTRANSPLANTATION IN MAN JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1964; 187 (10): 691-&	15	53	1	10
225	231 PORTER KA, ANDRES GA, CALDER MW, DOSSETOR JB, HSU KC, et al. HUMAN RENAL TRANSPLANTS .2. IMMUNOFLUORESCENT AND IMMUNOFERRITIN STUDIES LABORATORY INVESTIGATION. 1968; 18 (2): 159-&	15	138	6	52
226	456 NAJARIAN JS, SIMMONS RL CLINICAL USE OF ANTILYMPHOCYTE GLOBULIN NEW ENGLAND JOURNAL OF MEDICINE. 1971; 285 (3): 158-&	15	51	8	47
227	1050 ZEEVI A, EIRAS G, BURCKART G, JAIN A, KRAGACK A, et al. BIOASSAY OF PLASMA SPECIMENS FROM LIVER-TRANSPLANT PATIENTS ON FK-506 IMMUNOSUPPRESSION TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 60-63	15	27	1	18
228	1643 MAZARIEGOS GV, RAMOS H, SHAPIRO R, ZEEVI A, FUNG JJ, et al. WEANING OF IMMUNOSUPPRESSION IN LONG-TERM RECIPIENTS OF LIVING-RELATED RENAL-TRANSPLANTS - A PRELIMINARY-STUDY TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 207-209	15	31	7	24
229	1684 HIRASAWA A, TSUJIMOTO G, OKUYAMA S, LI XK, IWAYA M, et al. POLYMERASE CHAIN-REACTION OF THE RAT SEX-DETERMINING REGION OF THE Y-CHROMOSOME AND ITS APPLICATION TO ESTIMATING A STATE OF SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGEN H-Y TRANSPLANTATION PROCEEDINGS. 1995 APR; 27 (2): 1598-1600	15	23	2	13
230	1754 ALARD P, MATRIANO JA, SOCARRAS S, ORTEGA MA, STREILEIN JW DETECTION OF DONOR-DERIVED CELLS BY POLYMERASE CHAIN-REACTION IN NEONATALLY TOLERANT MICE - MICROCHIMERISM FAILS TO PREDICT TOLERANCE TRANSPLANTATION. 1995 NOV 27; 60 (10): 1125-1130	15	32	3	24
#	Date / Author / Journal	LCS	GCS	LCR	CR
231	1822 Pham SM, Kormos RL, Hattler BG, Kawai A, Tsamandas AC, et al. A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1996 APR; 111 (4): 764-772	15	97	6	32
232	2100 Lu LN, Li W, Fu FM, Chambers FG, Qian SG, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival TRANSPLANTATION. 1997 DEC 27; 64 (12): 1808-1815	15	151	7	61
233	2171 Morita H, Sugiura K, Inaba M, Jin TN, Ishikawa J, et al. A strategy for organ allografts without using immunosuppressants or irradiation PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998 JUN 9; 95 (12): 6947-6952	15	55	4	35
234	2313 Thomson AW, Lu L Dendritic cells as regulators of immune reactivity: Implications for transplantation TRANSPLANTATION. 1999 JUL 15; 68 (1): 1-8	15	78	14	70
235	2469 Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, et al. Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses TRANSPLANTATION. 2000 DEC 27; 70 (12): 1675-1682	15	36	13	29
236	22 REEMTSMA K, MCCRACKEN BH, SCHLEGEL JU, PEARL M HETEROTRANSPLANTATION OF KIDNEY - 2 CLINICAL EXPERIENCES SCIENCE. 1964; 143 (360): 700-&	14	54	1	7
237	33 WILSON WEC, KIRKPATR.CH, TALMAGE DW SUPPRESSION OF IMMUNOLOGIC RESPONSIVENESS IN UREMIA ANNALS OF INTERNAL MEDICINE. 1965; 62 (1): 1-&	14	391	3	38
238	195 WEIL R, SIMMONS RL COMBINED IMMUNOSUPPRESSION FOR CANINE RENAL ALLOGRAFT PROLONGATION - ANTILYMPHOCYTE SERUM PLUS PREDNISOLONE OR AZATHIOPRINE ANNALS OF SURGERY. 1968; 167 (2): 239-&	14	21	1	24
239	742 BOREL JF CYCLOSPORIN-A - PRESENT EXPERIMENTAL STATUS TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 344-348	14	151	1	13
240	938 GORDON RD, IWATSUKI S, ESQUIVEL CO, Tzakis AG, TODO S, et al. LIVER-TRANSPLANTATION ACROSS ABO BLOOD-GROUPS SURGERY. 1986 AUG; 100 (2): 342-348	14	133	5	16
#	Date / Author / Journal	LCS	GCS	LCR	CR
241	950 SOMMER BG, HENRY M, FERGUSON RM SEQUENTIAL ANTILYMPHOBLAST GLOBULIN AND CYCLOSPORINE FOR RENAL-TRANSPLANTATION TRANSPLANTATION. 1987 JAN; 43 (1): 85-90	14	101	4	25
242	989 AUCHINCLOSS H XENOGENEIC TRANSPLANTATION - A REVIEW TRANSPLANTATION. 1988 JUL; 46 (1): 1-20	14	516	17	356
243	1108 JOHANSSON A, MOLLER E EVIDENCE THAT THE IMMUNOSUPPRESSIVE EFFECTS OF FK506 AND CYCLOSPORINE ARE IDENTICAL TRANSPLANTATION. 1990 DEC; 50 (6): 1001-1007	14	69	2	27
244	1129 SUMRANI NB, DELANEY V, DING ZK, DAVIS R, DASKALAKIS P, et al. DIABETES-MELLITUS AFTER RENAL-TRANSPLANTATION IN THE CYCLOSPORINE ERA - AN ANALYSIS OF RISK-FACTORS TRANSPLANTATION. 1991 FEB; 51 (2): 343-347	14	159	8	35
245	1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 OCT; 56 (4): 847-853	14	73	15	50
246	1453 THOMSON AW, STARZL TE NEW IMMUNOSUPPRESSIVE DRUGS - MECHANISTIC INSIGHTS AND POTENTIAL THERAPEUTIC ADVANCES IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 71-98	14	91	12	90
247	1512 WINKLER M, CHRISTIANS U, STOLL K, BAUMANN J, PICHLMAYR R COMPARISON OF DIFFERENT ASSAYS FOR THE QUANTITATION OF FK-506 LEVELS IN BLOOD OR PLASMA THERAPEUTIC DRUG MONITORING. 1994 JUN; 16 (3): 281-286	14	25	6	13
248	1604 Ricordi C, Karatzas T, Selvaggi G, Nery J, Webb M, et al. Multiple bone marrow infusions to enhance acceptance of allografts from the same donor BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY. 1995; 770: 345-350	14	26	8	23
249	1732 KEENAN RJ, KONISHI H, KAWAI A, PARADIS IL, NUNLEY DR, et al. CLINICAL-TRIAL OF TACROLIMUS VERSUS CYCLOSPORINE IN LUNG TRANSPLANTATION ANNALS OF THORACIC SURGERY. 1995 SEP; 60 (3): 580-585	14	122	5	15
250	1740 PHAM SM, KEENAN RJ, RAO AS, FONTES PA, KORMOS RL, et al. PERIOPERATIVE DONOR BONE-MARROW INFUSION AUGMENTS CHIMERISM IN HEART AND LUNG-TRANSPLANT RECIPIENTS ANNALS OF THORACIC SURGERY. 1995 OCT; 60 (4): 1015-1020	14	26	7	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
251	1774 Thomson AW, Lu L, Wan YH, Qian SG, Larsen CP, et al. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients TRANSPLANTATION. 1995 DEC 27; 60 (12): 1555-1559	14	32	9	26
252	1883 Steptoe RJ, Thomson AW Dendritic cells and tolerance induction CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1996 SEP; 105 (3): 397-402	14	86	8	91
253	2184 Spriewald BM, Wassmuth R, Carl HD, Kockerling F, Reichstetter S, et al. Microchimerism after liver transplantation - Prevalence and methodological aspects of detection TRANSPLANTATION. 1998 JUL 15; 66 (1): 77-83	14	22	12	27
254	2455 Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection LIVER TRANSPLANTATION. 2000 NOV; 6 (6): 686-702	14	23	22	89
255	2813 Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus TRANSPLANTATION. 2004 OCT 15; 78 (7): 966-971	14	80	6	20
256	2936 Lerut J, Sanchez-Fueyo A An appraisal of tolerance in liver transplantation AMERICAN JOURNAL OF TRANSPLANTATION. 2006 AUG; 6 (8): 1774-1780	14	62	15	31
257	48 MOWBRAY JF, COHEN SL, DOAK PB, KENYON JR, OWEN K, et al. HUMAN CADAVERIC RENAL TRANSPLANTATION - REPORT OF 20 CASES BRITISH MEDICAL JOURNAL. 1965; 2 (5475): 1387-&	13	56	6	32
258	60 KOUNTZ SL, LAUB DR, COHN R DETECTING AND TREATING EARLY RENAL HOMOTRANSPLANT REJECTION JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1965; 191 (12): 997-&	13	57	3	12
259	75 KAUFFMAN HM, CLEVELAN.RJ, DWYER JJ, LEE HM, HUME DM PROLONGATION OF RENAL HOMOGRAFT FUNCTION BY LOCAL GRAFT RADIATION SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY. 1965; 120 (1): 49-&	13	60	1	19
260	90 PORTER KA, RENDALL JM, STOLINSK.C, TERASAKI PI, MARCHIOR.TL, et al. LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOBSIES FROM 33 HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 13/4-21/2 YEARS AFTER TRANSPLANTATION ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1966; 129 (A1): 615-&	13	53	6	35
#	Date / Author / Journal	LCS	GCS	LCR	CR
261	179 WILLIAMS GM, LEE HM, WEYMOUTH RF, HARLAN WR, HOLDEN KR, et al. STUDIES IN HYPERACUTE AND CHRONIC RENAL HOMOGRAFT REJECTION IN MAN SURGERY. 1967; 62 (1): 204-&	13	99	1	17
262	306 GREAVES MF, TORRIGIA.G, TURSI A, ZAMIR R, PLAYFAIR JH, et al. IMMUNOSUPPRESSIVE POTENCY AND IN-VITRO ACTIVITY OF ANTILYMPHOCYTE GLOBULIN LANCET. 1969; 1 (7585): 68-&	13	142	3	26
263	364 STARZL TE, GROTH CG, PUTNAM CW, PENN I, HALGRIMS.CG, et al. UROLOGICAL COMPLICATIONS IN 216 HUMAN RECIPIENTS OF RENAL TRANSPLANTS ANNALS OF SURGERY. 1970; 172 (1): 1-&	13	210	7	32
264	736 THOMSON AW, WHITING PH, BLAIR JT, DAVIDSON RJL, SIMPSON JG PATHOLOGICAL-CHANGES DEVELOPING IN THE RAT DURING A 3-WEEK COURSE OF HIGH DOSAGE CYCLOSPORIN A AND THEIR REVERSAL FOLLOWING DRUG WITHDRAWAL TRANSPLANTATION. 1981; 32 (4): 271-277	13	136	2	34
265	744 FILO RS, SMITH EJ, LEAPMAN SB REVERSAL OF ACUTE RENAL-ALLOGRAFT REJECTION WITH ADJUNCTIVE ATG THERAPY TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 482-490	13	35	4	19
266	800 NOVICK AC, BRAUN WE, STEINMULLER D, BUSZTA C, GREENSTREET R, et al. A CONTROLLED RANDOMIZED DOUBLE-BLIND-STUDY OF ANTILYMPHOBLAST GLOBULIN IN CADAVER RENAL-TRANSPLANTATION TRANSPLANTATION. 1983; 35 (2): 175-179	13	48	3	13
267	819 STARZL TE, HAKALA TR, ROSENTHAL JT, IWATSUKI S, SHAW BW THE COLORADO-PITTSBURGH CADAVERIC RENAL-TRANSPLANTATION STUDY WITH CYCLOSPORINE TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2459-2462	13	81	6	7
268	1064 JONES TK, REAMER RA, DESMOND R, MILLS SG CHEMISTRY OF TRICARBONYL HEMIKETALS AND APPLICATION OF EVANS TECHNOLOGY TO THE TOTAL SYNTHESIS OF THE IMMUNOSUPPRESSANT (-)-FK-506 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 1990 APR 11; 112 (8): 2998-3017	13	156	1	62
269	1072 ROSEN MK, STANDAERT RF, GALAT A, NAKATSUKA M, SCHREIBER SL INHIBITION OF FKBP ROTAMASE ACTIVITY BY IMMUNOSUPPRESSANT FK506 - TWISTED AMIDE SURROGATE SCIENCE. 1990 MAY 18; 248 (4957): 863-866	13	167	1	36
270	1081 NAKATSUKA M, RAGAN JA, SAMMAKIA T, SMITH DB, UEHLING DE, et al. TOTAL SYNTHESIS OF FK506 AND AN FKBP PROBE REAGENT, (C8,C9-(C-13)2)-FK506 JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 1990 JUL 4; 112 (14): 5583-5601	13	208	1	104
#	Date / Author / Journal	LCS	GCS	LCR	CR
271	1164 HUBSCHER SG, BUCKELS JAC, ELIAS E, MCMASTER P, NEUBERGER J VANISHING BILE-DUCT SYNDROME FOLLOWING LIVER-TRANSPLANTATION - IS IT REVERSIBLE TRANSPLANTATION. 1991 MAY; 51 (5): 1004-1010	13	72	2	23
272	1180 HULTSCH T, ALBERS MW, SCHREIBER SL, HOHMAN RJ IMMUNOPHILIN LIGANDS DEMONSTRATE COMMON FEATURES OF SIGNAL TRANSDUCTION LEADING TO EXOCYTOSIS OR TRANSCRIPTION PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1991 JUL; 88 (14): 6229-6233	13	131	4	33
273	1201 WIESNER RH, LUDWIG J, VANHOEK B, KROM RAF CURRENT CONCEPTS IN CELL-MEDIATED HEPATIC ALLOGRAFT-REJECTION LEADING TO DUCTOPENIA AND LIVER-FAILURE HEPATOLOGY. 1991 OCT; 14 (4): 721-729	13	101	1	62
274	1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al. EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION TRANSPLANTATION. 1993 FEB; 55 (2): 288-292	13	53	10	19
275	1444 WALLEMACQ PE, REDING R FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS CLINICAL CHEMISTRY. 1993 NOV; 39 (11): 2219-2228	13	81	22	101
276	1494 KUBIT V, SONMEZALPAN E, ZEEVI A, PARADIS I, DAUBER JH, et al. MIXED ALLOGENEIC CHIMERISM IN LUNG ALLOGRAFT RECIPIENTS HUMAN PATHOLOGY. 1994 APR; 25 (4): 408-412	13	22	5	26
277	1633 MASAKI Y, HIRASAWA A, OKUYAMA S, TSUJIMOTO G, IWAYA M, et al. MICROCHIMERISM AND HEART ALLOGRAFT ACCEPTANCE TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 148-150	13	18	3	7
278	1746 BRENNAN DC, MOHANAKUMAR T, FLYE MW DONOR-SPECIFIC TRANSFUSION AND DONOR BONE-MARROW INFUSION IN RENAL-TRANSPLANTATION TOLERANCE - A REVIEW OF EFFICACY AND MECHANISMS AMERICAN JOURNAL OF KIDNEY DISEASES. 1995 NOV; 26 (5): 701-715	13	54	7	130
279	1753 ANAND AC, HUBSCHER SG, GUNSON BK, MCMASTER P, NEUBERGER JM TIMING, SIGNIFICANCE, AND PROGNOSIS OF LATE ACUTE LIVER ALLOGRAFT-REJECTION TRANSPLANTATION. 1995 NOV 27; 60 (10): 1098-1103	13	63	6	28
280	1761 JUSKO WJ, THOMSON AW, Fung JJ, MCMASTER P, WONG SH, et al. CONSENSUS DOCUMENT - THERAPEUTIC MONITORING OF TACROLIMUS (FK-506) THERAPEUTIC DRUG MONITORING. 1995 DEC; 17 (6): 606-614	13	156	17	55
#	Date / Author / Journal	LCS	GCS	LCR	CR
281	2005 Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation BLOOD. 1997 APR 15; 89 (8): 3048-3054	13	410	5	31
282	2016 Adams DH, Hutchinson IV Microchimerism and graft tolerance: Cause or effect? LANCET. 1997 MAY 10; 349 (9062): 1336-1337	13	24	5	10
283	2173 Qian SG, Lu L, Fu FM, Li W, Pan F, et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity TRANSPLANTATION. 1998 JUN 27; 65 (12): 1590-1598	13	31	22	53
284	2319 Salgar SK, Shapiro R, Dodson F, Corry R, McCurry K, et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients JOURNAL OF LEUKOCYTE BIOLOGY. 1999 AUG; 66 (2): 310-314	13	28	7	16
285	2585 Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, et al. Chimerism of the transplanted heart NEW ENGLAND JOURNAL OF MEDICINE. 2002 JAN 3; 346 (1): 5-15	13	660	4	39
286	2621 Mathes DW, Randolph MA, Bourget JL, Nielsen GP, Ferrera VR, et al. Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft TRANSPLANTATION. 2002 JUN 27; 73 (12): 1880-1885	13	17	8	31
287	2972 Mazariegos GV, Sindhi R, Thomson AW, Marcos A Clinical tolerance following liver transplantation: Long term results and future prospects TRANSPLANT IMMUNOLOGY. 2007 FEB; 17 (2): 114-119	13	32	21	46
288	142 RAPAPORT FT, DAUSSET J, HAMBURGE.J, HUME DM, KANO K, et al. SEROLOGIC FACTORS IN HUMAN TRANSPLANTATION ANNALS OF SURGERY. 1967; 166 (4): 596-&	12	55	2	59
289	322 JAMES K PREPARATION AND PROPERTIES OF ANTI-LYMPHOCYTIC SERA PROGRESS IN SURGERY. 1969; 7: 140-&	12	69	11	141
290	389 NAJARIAN JS, SIMMONS RL, GEWURZ H, MOBERG A, MERKEL F, et al. ANTIHUMAN LYMPHOBLAST GLOBULIN FEDERATION PROCEEDINGS. 1970; 29 (1): 197-&	12	30	4	29
#	Date / Author / Journal	LCS	GCS	LCR	CR
291	409 SIMMONS RL, MOBERG AW, GEWURZ H, SOLL R, TALLENT MB, et al. IMMUNOSUPPRESSIVE ASSAY OF ANTILYMPHOBLAST GLOBULIN IN MAN - EFFECT OF DOSE, HISTOCOMPATIBILITY, AND SEROLOGIC RESPONSE TO HORSE GAMMA GLOBULIN SURGERY. 1970; 68 (1): 62-&	12	32	3	15
292	574 HILL CM, DOUGLAS JF, RAJKUMAR KV, MCEVOY J, MCGEOWN MG GLYCOSURIA AND HYPERGLYCEMIA AFTER KIDNEY-TRANSPLANTATION LANCET. 1974; 2 (7879): 490-492	12	34	2	15
293	638 MONACO AP, CODISH SD SURVEY OF CURRENT STATUS OF CLINICAL USES OF ANTILYMPHOCYTE-SERUM SURGERY GYNECOLOGY & OBSTETRICS. 1976; 142 (3): 417-426	12	34	5	50
294	710 FILO RS, SMITH EJ, LEAPMAN SB THERAPY OF ACUTE CADAVERIC RENAL-ALLOGRAFT REJECTION WITH ADJUNCTIVE ANTI-THYMOCYTE GLOBULIN TRANSPLANTATION. 1980; 30 (6): 445-449	12	71	4	20
295	726 HAMILTON DV, CALNE RY, EVANS DB, HENDERSON RG, THIRU S, et al. THE EFFECT OF LONG-TERM CYCLOSPORIN A ON RENAL-FUNCTION LANCET. 1981; 1 (8231): 1218-1219	12	53	3	9
296	762 STARZL TE, MALATACK JJ, GARTNER JC, ROSENTHAL JT LIVER AND KIDNEY-TRANSPLANTATION IN CHILDREN RECEIVING CYCLOSPORIN-A AND STEROIDS JOURNAL OF PEDIATRICS. 1982; 100 (5): 681-686	12	49	14	28
297	1092 WICKER LS, BOLTZ RC, MATT V, NICHOLS EA, PETERSON LB, et al. SUPPRESSION OF B-CELL ACTIVATION BY CYCLOSPORINE-A, FK506 AND RAPAMYCIN EUROPEAN JOURNAL OF IMMUNOLOGY. 1990 OCT; 20 (10): 2277-2283	12	113	1	37
298	1093 STARZL TE, SCHROTER GPJ, HARTMANN NJ, BARFIELD N, TAYLOR P, et al. LONG-TERM (25-YEAR) SURVIVAL AFTER RENAL HOMOTRANSPLANTATION - THE WORLD EXPERIENCE TRANSPLANTATION PROCEEDINGS. 1990 OCT; 22 (5): 2361-2365	12	23	8	30
299	1135 Tzakis AG, FUNG JJ, TODO S, REYES J, GREEN M, et al. USE OF FK506 IN PEDIATRIC-PATIENTS TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 924-927	12	43	11	24
300	1160 DEPAULIS A, CIRILLO R, CICCARELLI A, CONDORELLI M, MARONE G FK-506, A POTENT NOVEL INHIBITOR OF THE RELEASE OF PROINFLAMMATORY MEDIATORS FROM HUMAN FC-EPSILON-RI+ CELLS JOURNAL OF IMMUNOLOGY. 1991 APR 1; 146 (7): 2374-2381	12	99	2	60

Date / Author / Journal

LCS

GCS

LCR

201

2281 Sakamoto T, Ye Q, Lu L, Demetris AJ, Starzl TE, et al.

Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts

TRANSPLANTATION. 1999 MAR 27; 67 (6): 833-840

202

2322 Wekerle T, Sykes M

Mixed chimerism as an approach for the induction of transplantation tolerance

TRANSPLANTATION. 1999 AUG 27; 68 (4): 459-467

103

117

203

2430 VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, et al.

Human allograft acceptance is associated with immune regulation

JOURNAL OF CLINICAL INVESTIGATION. 2000 JUL; 106 (1): 145-155

171

204

2468 Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, et al.

Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both

TRANSPLANTATION. 2000 DEC 15; 70 (11): 1632-1641

205

3 STARZL TE, RIFKIND D, MOORE CA, WADDELL WR, PORTER KA, et al.

RENAL HOMOTRANSPLANTATION - LATE FUNTION + COMPLICATIONS

ANNALS OF INTERNAL MEDICINE. 1964; 61 (3): 470-&

104

206

10 DEMPSTER WJ, SHACKMAN R, HARRISON CV

REJECTION PROCESSES IN HUMAN HOMOTRANSPLANTED KIDNEYS

BRITISH MEDICAL JOURNAL. 1964; 2 (541): 969-&

207

17 PORTER KA, ZUKOSKI CF, CALNE RY

VASCULAR + OTHER CHANGES IN 200 CANINE RENAL HOMOTRANSPLANTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS

LABORATORY INVESTIGATION. 1964; 13 (7): 809-&

208

718 BEVERIDGE T, GRATWOHL A, MICHOT F, NIEDERBERGER W, NUESCH E, et al.

CYCLOSPORIN-A - PHARMACOKINETICS AFTER A SINGLE DOSE IN MAN AND SERUM LEVELS AFTER MULTIPLE DOSING IN RECIPIENTS OF ALLOGENEIC BONE-MARROW GRAFTS

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. 1981; 30 (1): 5-18

161

209

741 IWATSUKI S, IWAKI Y, KANO T, KLINTMALM G, KOEP LJ, et al.

SUCCESSFUL LIVER-TRANSPLANTATION FROM CROSSMATCH-POSITIVE DONORS

TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 286-288

210

1227 Tzakis AG, REYES J, TODO S, GREEN M, OHYA T, et al.

FK-506 VERSUS CYCLOSPORINE IN PEDIATRIC LIVER-TRANSPLANTATION

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3010-3015

Date / Author / Journal

LCS

GCS

LCR

211

1239 MCCAULEY J, FUNG JJ, TODO S, JAIN A, DEBALLI P, et al.

CHANGES IN RENAL-FUNCTION AFTER LIVER-TRANSPLANTATION UNDER FK-506

TRANSPLANTATION PROCEEDINGS. 1991 DEC; 23 (6): 3143-3145

212

1470 REDING R, WALLEMACQ PE, LAMY ME, RAHIER J, SEMPOUX C, et al.

CONVERSION FROM CYCLOSPORINE TO FK506 FOR SALVAGE OF IMMUNOCOMPROMISED PEDIATRIC LIVER ALLOGRAFTS - EFFICACY, TOXICITY, AND DOSE REGIMEN IN 23 CHILDREN

TRANSPLANTATION. 1994 JAN; 57 (1): 93-100

213

1482 BACKMAN L, NICAR M, LEVY M, DISTANT D, EISENSTEIN C, et al.

FK506 TROUGH LEVELS IN WHOLE-BLOOD AND PLASMA IN LIVER-TRANSPLANT RECIPIENTS - CORRELATION WITH CLINICAL EVENTS AND SIDE-EFFECTS

TRANSPLANTATION. 1994 FEB 27; 57 (4): 519-525

214

1519 PEARSON TC, ALEXANDER DZ, WINN KJ, LINSLEY PS, LOWRY RP, et al.

TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-IG

TRANSPLANTATION. 1994 JUN 27; 57 (12): 1701-1706

281

215

1618 NEUHAUS P, BLUMHARDT G, BECHSTEIN WO, PLATZ KP, JONAS S, et al.

COMPARISON OF FK506-BASED AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER- TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE

TRANSPLANTATION. 1995 JAN 15; 59 (1): 31-40

103

216

1757 Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, et al.

Clinical pharmacokinetics of tacrolimus

CLINICAL PHARMACOKINETICS. 1995 DEC; 29 (6): 404-430

291

147

217

2024 Ueda M, Hundrieser J, Hisanaga M, Tanaka K, Wonigeit K, et al.

Development of microchimerism in pediatric patients after living-related liver transplantation

CLINICAL TRANSPLANTATION. 1997 JUN; 11 (3): 193-200

218

2334 Lu L, Li W, Zhong CP, Qian SG, Fung JJ, et al.

Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb

TRANSPLANTATION. 1999 SEP 27; 68 (6): 747-757

219

2472 Wekerle T, Sykes M

Mixed chimerism and transplantation tolerance

ANNUAL REVIEW OF MEDICINE. 2001; 52: 353-+

106

220

2693 Pons JA, Yelamos J, Ramirez P, Oliver-Bonet M, Sanchez A, et al.

Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression

TRANSPLANTATION. 2003 APR 15; 75 (7): 1045-1047

Date / Author / Journal

LCS

GCS

LCR

221

2773 Starzl TE, Murase N, Demetris AJ, Trucco M, Abu-Elmagd K, et al.

Lessons of organ-induced tolerance learned from historical clinical experience

TRANSPLANTATION. 2004 MAR 27; 77 (6): 926-929

222

2917 Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, et al.

Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence

JOURNAL OF HEPATOLOGY. 2006 APR; 44 (4): 702-709

223

3029 Alexander SI, Smith N, Hu M, Verran D, Shun A, et al.

Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 369-374

224

13 REEMTSMA K, SCHLEGEL JU, DEWITT CW, MCCRACKEN BH, PEARL MA, et al.

REVERSAL OF EARLY GRAFT REJECTION AFTER RENAL HETEROTRANSPLANTATION IN MAN

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1964; 187 (10): 691-&

225

231 PORTER KA, ANDRES GA, CALDER MW, DOSSETOR JB, HSU KC, et al.

HUMAN RENAL TRANSPLANTS .2. IMMUNOFLUORESCENT AND IMMUNOFERRITIN STUDIES

LABORATORY INVESTIGATION. 1968; 18 (2): 159-&

138

226

456 NAJARIAN JS, SIMMONS RL

CLINICAL USE OF ANTILYMPHOCYTE GLOBULIN

NEW ENGLAND JOURNAL OF MEDICINE. 1971; 285 (3): 158-&

227

1050 ZEEVI A, EIRAS G, BURCKART G, JAIN A, KRAGACK A, et al.

BIOASSAY OF PLASMA SPECIMENS FROM LIVER-TRANSPLANT PATIENTS ON FK-506 IMMUNOSUPPRESSION

TRANSPLANTATION PROCEEDINGS. 1990 FEB; 22 (1): 60-63

228

1643 MAZARIEGOS GV, RAMOS H, SHAPIRO R, ZEEVI A, FUNG JJ, et al.

WEANING OF IMMUNOSUPPRESSION IN LONG-TERM RECIPIENTS OF LIVING-RELATED RENAL-TRANSPLANTS - A PRELIMINARY-STUDY

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 207-209

229

1684 HIRASAWA A, TSUJIMOTO G, OKUYAMA S, LI XK, IWAYA M, et al.

POLYMERASE CHAIN-REACTION OF THE RAT SEX-DETERMINING REGION OF THE Y-CHROMOSOME AND ITS APPLICATION TO ESTIMATING A STATE OF SENSITIZATION TO MINOR HISTOCOMPATIBILITY ANTIGEN H-Y

TRANSPLANTATION PROCEEDINGS. 1995 APR; 27 (2): 1598-1600

230

1754 ALARD P, MATRIANO JA, SOCARRAS S, ORTEGA MA, STREILEIN JW

DETECTION OF DONOR-DERIVED CELLS BY POLYMERASE CHAIN-REACTION IN NEONATALLY TOLERANT MICE - MICROCHIMERISM FAILS TO PREDICT TOLERANCE

TRANSPLANTATION. 1995 NOV 27; 60 (10): 1125-1130

Date / Author / Journal

LCS

GCS

LCR

231

1822 Pham SM, Kormos RL, Hattler BG, Kawai A, Tsamandas AC, et al.

A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 1996 APR; 111 (4): 764-772

232

2100 Lu LN, Li W, Fu FM, Chambers FG, Qian SG, et al.

Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival

TRANSPLANTATION. 1997 DEC 27; 64 (12): 1808-1815

151

233

2171 Morita H, Sugiura K, Inaba M, Jin TN, Ishikawa J, et al.

A strategy for organ allografts without using immunosuppressants or irradiation

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998 JUN 9; 95 (12): 6947-6952

234

2313 Thomson AW, Lu L

Dendritic cells as regulators of immune reactivity: Implications for transplantation

TRANSPLANTATION. 1999 JUL 15; 68 (1): 1-8

235

2469 Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, et al.

Donor bone marrow-derived chimeric cells present in renal, transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses

TRANSPLANTATION. 2000 DEC 27; 70 (12): 1675-1682

236

22 REEMTSMA K, MCCRACKEN BH, SCHLEGEL JU, PEARL M

HETEROTRANSPLANTATION OF KIDNEY - 2 CLINICAL EXPERIENCES

SCIENCE. 1964; 143 (360): 700-&

237

33 WILSON WEC, KIRKPATR.CH, TALMAGE DW

SUPPRESSION OF IMMUNOLOGIC RESPONSIVENESS IN UREMIA

ANNALS OF INTERNAL MEDICINE. 1965; 62 (1): 1-&

391

238

195 WEIL R, SIMMONS RL

COMBINED IMMUNOSUPPRESSION FOR CANINE RENAL ALLOGRAFT PROLONGATION - ANTILYMPHOCYTE SERUM PLUS PREDNISOLONE OR AZATHIOPRINE

ANNALS OF SURGERY. 1968; 167 (2): 239-&

239

742 BOREL JF

CYCLOSPORIN-A - PRESENT EXPERIMENTAL STATUS

TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 344-348

151

240

938 GORDON RD, IWATSUKI S, ESQUIVEL CO, Tzakis AG, TODO S, et al.

LIVER-TRANSPLANTATION ACROSS ABO BLOOD-GROUPS

SURGERY. 1986 AUG; 100 (2): 342-348

133

Date / Author / Journal

LCS

GCS

LCR

241

950 SOMMER BG, HENRY M, FERGUSON RM

SEQUENTIAL ANTILYMPHOBLAST GLOBULIN AND CYCLOSPORINE FOR RENAL-TRANSPLANTATION

TRANSPLANTATION. 1987 JAN; 43 (1): 85-90

101

242

989 AUCHINCLOSS H

XENOGENEIC TRANSPLANTATION - A REVIEW

TRANSPLANTATION. 1988 JUL; 46 (1): 1-20

516

356

243

1108 JOHANSSON A, MOLLER E

EVIDENCE THAT THE IMMUNOSUPPRESSIVE EFFECTS OF FK506 AND CYCLOSPORINE ARE IDENTICAL

TRANSPLANTATION. 1990 DEC; 50 (6): 1001-1007

244

1129 SUMRANI NB, DELANEY V, DING ZK, DAVIS R, DASKALAKIS P, et al.

DIABETES-MELLITUS AFTER RENAL-TRANSPLANTATION IN THE CYCLOSPORINE ERA - AN ANALYSIS OF RISK-FACTORS

TRANSPLANTATION. 1991 FEB; 51 (2): 343-347

159

245

1437 MCDIARMID SV, COLONNA JO, SHAKED A, AMENT ME, BUSUTTIL RW

A COMPARISON OF RENAL-FUNCTION IN CYCLOSPORINE-TREATED AND FK-506-TREATED PATIENTS AFTER PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 OCT; 56 (4): 847-853

246

1453 THOMSON AW, STARZL TE

NEW IMMUNOSUPPRESSIVE DRUGS - MECHANISTIC INSIGHTS AND POTENTIAL THERAPEUTIC ADVANCES

IMMUNOLOGICAL REVIEWS. 1993 DEC; 136: 71-98

247

1512 WINKLER M, CHRISTIANS U, STOLL K, BAUMANN J, PICHLMAYR R

COMPARISON OF DIFFERENT ASSAYS FOR THE QUANTITATION OF FK-506 LEVELS IN BLOOD OR PLASMA

THERAPEUTIC DRUG MONITORING. 1994 JUN; 16 (3): 281-286

248

1604 Ricordi C, Karatzas T, Selvaggi G, Nery J, Webb M, et al.

Multiple bone marrow infusions to enhance acceptance of allografts from the same donor

BONE MARROW TRANSPLANTATION: FOUNDATIONS FOR THE 21ST CENTURY. 1995; 770: 345-350

249

1732 KEENAN RJ, KONISHI H, KAWAI A, PARADIS IL, NUNLEY DR, et al.

CLINICAL-TRIAL OF TACROLIMUS VERSUS CYCLOSPORINE IN LUNG TRANSPLANTATION

ANNALS OF THORACIC SURGERY. 1995 SEP; 60 (3): 580-585

122

250

1740 PHAM SM, KEENAN RJ, RAO AS, FONTES PA, KORMOS RL, et al.

PERIOPERATIVE DONOR BONE-MARROW INFUSION AUGMENTS CHIMERISM IN HEART AND LUNG-TRANSPLANT RECIPIENTS

ANNALS OF THORACIC SURGERY. 1995 OCT; 60 (4): 1015-1020

Date / Author / Journal

LCS

GCS

LCR

251

1774 Thomson AW, Lu L, Wan YH, Qian SG, Larsen CP, et al.

Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients

TRANSPLANTATION. 1995 DEC 27; 60 (12): 1555-1559

252

1883 Steptoe RJ, Thomson AW

Dendritic cells and tolerance induction

CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1996 SEP; 105 (3): 397-402

253

2184 Spriewald BM, Wassmuth R, Carl HD, Kockerling F, Reichstetter S, et al.

Microchimerism after liver transplantation - Prevalence and methodological aspects of detection

TRANSPLANTATION. 1998 JUL 15; 66 (1): 77-83

254

2455 Ichikawa N, Demetris AJ, Starzl TE, Ye Q, Okuda T, et al.

Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection

LIVER TRANSPLANTATION. 2000 NOV; 6 (6): 686-702

255

2813 Marcos A, Eghtesad B, Fung JJ, Fontes P, Patel K, et al.

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus

TRANSPLANTATION. 2004 OCT 15; 78 (7): 966-971

256

2936 Lerut J, Sanchez-Fueyo A

An appraisal of tolerance in liver transplantation

AMERICAN JOURNAL OF TRANSPLANTATION. 2006 AUG; 6 (8): 1774-1780

257

48 MOWBRAY JF, COHEN SL, DOAK PB, KENYON JR, OWEN K, et al.

HUMAN CADAVERIC RENAL TRANSPLANTATION - REPORT OF 20 CASES

BRITISH MEDICAL JOURNAL. 1965; 2 (5475): 1387-&

258

60 KOUNTZ SL, LAUB DR, COHN R

DETECTING AND TREATING EARLY RENAL HOMOTRANSPLANT REJECTION

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 1965; 191 (12): 997-&

259

75 KAUFFMAN HM, CLEVELAN.RJ, DWYER JJ, LEE HM, HUME DM

PROLONGATION OF RENAL HOMOGRAFT FUNCTION BY LOCAL GRAFT RADIATION

SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY. 1965; 120 (1): 49-&

260

90 PORTER KA, RENDALL JM, STOLINSK.C, TERASAKI PI, MARCHIOR.TL, et al.

LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOBSIES FROM 33 HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 13/4-21/2 YEARS AFTER TRANSPLANTATION

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1966; 129 (A1): 615-&

Date / Author / Journal

LCS

GCS

LCR

261

179 WILLIAMS GM, LEE HM, WEYMOUTH RF, HARLAN WR, HOLDEN KR, et al.

STUDIES IN HYPERACUTE AND CHRONIC RENAL HOMOGRAFT REJECTION IN MAN

SURGERY. 1967; 62 (1): 204-&

262

306 GREAVES MF, TORRIGIA.G, TURSI A, ZAMIR R, PLAYFAIR JH, et al.

IMMUNOSUPPRESSIVE POTENCY AND IN-VITRO ACTIVITY OF ANTILYMPHOCYTE GLOBULIN

LANCET. 1969; 1 (7585): 68-&

142

263

364 STARZL TE, GROTH CG, PUTNAM CW, PENN I, HALGRIMS.CG, et al.

UROLOGICAL COMPLICATIONS IN 216 HUMAN RECIPIENTS OF RENAL TRANSPLANTS

ANNALS OF SURGERY. 1970; 172 (1): 1-&

210

264

736 THOMSON AW, WHITING PH, BLAIR JT, DAVIDSON RJL, SIMPSON JG

PATHOLOGICAL-CHANGES DEVELOPING IN THE RAT DURING A 3-WEEK COURSE OF HIGH DOSAGE CYCLOSPORIN A AND THEIR REVERSAL FOLLOWING DRUG WITHDRAWAL

TRANSPLANTATION. 1981; 32 (4): 271-277

136

265

744 FILO RS, SMITH EJ, LEAPMAN SB

REVERSAL OF ACUTE RENAL-ALLOGRAFT REJECTION WITH ADJUNCTIVE ATG THERAPY

TRANSPLANTATION PROCEEDINGS. 1981; 13 (1): 482-490

266

800 NOVICK AC, BRAUN WE, STEINMULLER D, BUSZTA C, GREENSTREET R, et al.

A CONTROLLED RANDOMIZED DOUBLE-BLIND-STUDY OF ANTILYMPHOBLAST GLOBULIN IN CADAVER RENAL-TRANSPLANTATION

TRANSPLANTATION. 1983; 35 (2): 175-179

267

819 STARZL TE, HAKALA TR, ROSENTHAL JT, IWATSUKI S, SHAW BW

THE COLORADO-PITTSBURGH CADAVERIC RENAL-TRANSPLANTATION STUDY WITH CYCLOSPORINE

TRANSPLANTATION PROCEEDINGS. 1983; 15 (4): 2459-2462

268

1064 JONES TK, REAMER RA, DESMOND R, MILLS SG

CHEMISTRY OF TRICARBONYL HEMIKETALS AND APPLICATION OF EVANS TECHNOLOGY TO THE TOTAL SYNTHESIS OF THE IMMUNOSUPPRESSANT (-)-FK-506

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 1990 APR 11; 112 (8): 2998-3017

156

269

1072 ROSEN MK, STANDAERT RF, GALAT A, NAKATSUKA M, SCHREIBER SL

INHIBITION OF FKBP ROTAMASE ACTIVITY BY IMMUNOSUPPRESSANT FK506 - TWISTED AMIDE SURROGATE

SCIENCE. 1990 MAY 18; 248 (4957): 863-866

167

270

1081 NAKATSUKA M, RAGAN JA, SAMMAKIA T, SMITH DB, UEHLING DE, et al.

TOTAL SYNTHESIS OF FK506 AND AN FKBP PROBE REAGENT, (C8,C9-(C-13)2)-FK506

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 1990 JUL 4; 112 (14): 5583-5601

208

104

Date / Author / Journal

LCS

GCS

LCR

271

1164 HUBSCHER SG, BUCKELS JAC, ELIAS E, MCMASTER P, NEUBERGER J

VANISHING BILE-DUCT SYNDROME FOLLOWING LIVER-TRANSPLANTATION - IS IT REVERSIBLE

TRANSPLANTATION. 1991 MAY; 51 (5): 1004-1010

272

1180 HULTSCH T, ALBERS MW, SCHREIBER SL, HOHMAN RJ

IMMUNOPHILIN LIGANDS DEMONSTRATE COMMON FEATURES OF SIGNAL TRANSDUCTION LEADING TO EXOCYTOSIS OR TRANSCRIPTION

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1991 JUL; 88 (14): 6229-6233

131

273

1201 WIESNER RH, LUDWIG J, VANHOEK B, KROM RAF

CURRENT CONCEPTS IN CELL-MEDIATED HEPATIC ALLOGRAFT-REJECTION LEADING TO DUCTOPENIA AND LIVER-FAILURE

HEPATOLOGY. 1991 OCT; 14 (4): 721-729

101

274

1344 UEMOTO S, TANAKA K, HONDA K, TOKUNAGA Y, SANO K, et al.

EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER-TRANSPLANTATION

TRANSPLANTATION. 1993 FEB; 55 (2): 288-292

275

1444 WALLEMACQ PE, REDING R

FK506 (TACROLIMUS), A NOVEL IMMUNOSUPPRESSANT IN ORGAN-TRANSPLANTATION - CLINICAL, BIOMEDICAL, AND ANALYTICAL ASPECTS

CLINICAL CHEMISTRY. 1993 NOV; 39 (11): 2219-2228

101

276

1494 KUBIT V, SONMEZALPAN E, ZEEVI A, PARADIS I, DAUBER JH, et al.

MIXED ALLOGENEIC CHIMERISM IN LUNG ALLOGRAFT RECIPIENTS

HUMAN PATHOLOGY. 1994 APR; 25 (4): 408-412

277

1633 MASAKI Y, HIRASAWA A, OKUYAMA S, TSUJIMOTO G, IWAYA M, et al.

MICROCHIMERISM AND HEART ALLOGRAFT ACCEPTANCE

TRANSPLANTATION PROCEEDINGS. 1995 FEB; 27 (1): 148-150

278

1746 BRENNAN DC, MOHANAKUMAR T, FLYE MW

DONOR-SPECIFIC TRANSFUSION AND DONOR BONE-MARROW INFUSION IN RENAL-TRANSPLANTATION TOLERANCE - A REVIEW OF EFFICACY AND MECHANISMS

AMERICAN JOURNAL OF KIDNEY DISEASES. 1995 NOV; 26 (5): 701-715

130

279

1753 ANAND AC, HUBSCHER SG, GUNSON BK, MCMASTER P, NEUBERGER JM

TIMING, SIGNIFICANCE, AND PROGNOSIS OF LATE ACUTE LIVER ALLOGRAFT-REJECTION

TRANSPLANTATION. 1995 NOV 27; 60 (10): 1098-1103

280

1761 JUSKO WJ, THOMSON AW, Fung JJ, MCMASTER P, WONG SH, et al.

CONSENSUS DOCUMENT - THERAPEUTIC MONITORING OF TACROLIMUS (FK-506)

THERAPEUTIC DRUG MONITORING. 1995 DEC; 17 (6): 606-614

156

Date / Author / Journal

LCS

GCS

LCR

281

2005 Storb R, Yu C, Wagner JL, Deeg HJ, Nash RA, et al.

Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation

BLOOD. 1997 APR 15; 89 (8): 3048-3054

410

282

2016 Adams DH, Hutchinson IV

Microchimerism and graft tolerance: Cause or effect?

LANCET. 1997 MAY 10; 349 (9062): 1336-1337

283

2173 Qian SG, Lu L, Fu FM, Li W, Pan F, et al.

Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity

TRANSPLANTATION. 1998 JUN 27; 65 (12): 1590-1598

284

2319 Salgar SK, Shapiro R, Dodson F, Corry R, McCurry K, et al.

Infusion of donor leukocytes to induce tolerance in organ allograft recipients

JOURNAL OF LEUKOCYTE BIOLOGY. 1999 AUG; 66 (2): 310-314

285

2585 Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, et al.

Chimerism of the transplanted heart

NEW ENGLAND JOURNAL OF MEDICINE. 2002 JAN 3; 346 (1): 5-15

660

286

2621 Mathes DW, Randolph MA, Bourget JL, Nielsen GP, Ferrera VR, et al.

Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft

TRANSPLANTATION. 2002 JUN 27; 73 (12): 1880-1885

287

2972 Mazariegos GV, Sindhi R, Thomson AW, Marcos A

Clinical tolerance following liver transplantation: Long term results and future prospects

TRANSPLANT IMMUNOLOGY. 2007 FEB; 17 (2): 114-119

288

142 RAPAPORT FT, DAUSSET J, HAMBURGE.J, HUME DM, KANO K, et al.

SEROLOGIC FACTORS IN HUMAN TRANSPLANTATION

ANNALS OF SURGERY. 1967; 166 (4): 596-&

289

322 JAMES K

PREPARATION AND PROPERTIES OF ANTI-LYMPHOCYTIC SERA

PROGRESS IN SURGERY. 1969; 7: 140-&

141

290

389 NAJARIAN JS, SIMMONS RL, GEWURZ H, MOBERG A, MERKEL F, et al.

ANTIHUMAN LYMPHOBLAST GLOBULIN

FEDERATION PROCEEDINGS. 1970; 29 (1): 197-&

Date / Author / Journal

LCS

GCS

LCR

291

409 SIMMONS RL, MOBERG AW, GEWURZ H, SOLL R, TALLENT MB, et al.

IMMUNOSUPPRESSIVE ASSAY OF ANTILYMPHOBLAST GLOBULIN IN MAN - EFFECT OF DOSE, HISTOCOMPATIBILITY, AND SEROLOGIC RESPONSE TO HORSE GAMMA GLOBULIN

SURGERY. 1970; 68 (1): 62-&

292

574 HILL CM, DOUGLAS JF, RAJKUMAR KV, MCEVOY J, MCGEOWN MG

GLYCOSURIA AND HYPERGLYCEMIA AFTER KIDNEY-TRANSPLANTATION

LANCET. 1974; 2 (7879): 490-492

293

638 MONACO AP, CODISH SD

SURVEY OF CURRENT STATUS OF CLINICAL USES OF ANTILYMPHOCYTE-SERUM

SURGERY GYNECOLOGY & OBSTETRICS. 1976; 142 (3): 417-426

294

710 FILO RS, SMITH EJ, LEAPMAN SB

THERAPY OF ACUTE CADAVERIC RENAL-ALLOGRAFT REJECTION WITH ADJUNCTIVE ANTI-THYMOCYTE GLOBULIN

TRANSPLANTATION. 1980; 30 (6): 445-449

295

726 HAMILTON DV, CALNE RY, EVANS DB, HENDERSON RG, THIRU S, et al.

THE EFFECT OF LONG-TERM CYCLOSPORIN A ON RENAL-FUNCTION

LANCET. 1981; 1 (8231): 1218-1219

296

762 STARZL TE, MALATACK JJ, GARTNER JC, ROSENTHAL JT

LIVER AND KIDNEY-TRANSPLANTATION IN CHILDREN RECEIVING CYCLOSPORIN-A AND STEROIDS

JOURNAL OF PEDIATRICS. 1982; 100 (5): 681-686

297

1092 WICKER LS, BOLTZ RC, MATT V, NICHOLS EA, PETERSON LB, et al.

SUPPRESSION OF B-CELL ACTIVATION BY CYCLOSPORINE-A, FK506 AND RAPAMYCIN

EUROPEAN JOURNAL OF IMMUNOLOGY. 1990 OCT; 20 (10): 2277-2283

113

298

1093 STARZL TE, SCHROTER GPJ, HARTMANN NJ, BARFIELD N, TAYLOR P, et al.

LONG-TERM (25-YEAR) SURVIVAL AFTER RENAL HOMOTRANSPLANTATION - THE WORLD EXPERIENCE

TRANSPLANTATION PROCEEDINGS. 1990 OCT; 22 (5): 2361-2365

299

1135 Tzakis AG, FUNG JJ, TODO S, REYES J, GREEN M, et al.

USE OF FK506 IN PEDIATRIC-PATIENTS

TRANSPLANTATION PROCEEDINGS. 1991 FEB; 23 (1): 924-927

300

1160 DEPAULIS A, CIRILLO R, CICCARELLI A, CONDORELLI M, MARONE G

FK-506, A POTENT NOVEL INHIBITOR OF THE RELEASE OF PROINFLAMMATORY MEDIATORS FROM HUMAN FC-EPSILON-RI+ CELLS

JOURNAL OF IMMUNOLOGY. 1991 APR 1; 146 (7): 2374-2381

The Kidney Transplant Papers 9 papers representing Starzl's ground breaking work in the area of kidney transplantation. And all the papers citing them from the SCI, AHCI, SSCI databases up-to-date as of May 2012	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012
List of All Records